These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22110765)

  • 41. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.
    Epalza C; Valadés-Alcaraz A; González-Alba JM; Beltrán-Pavez C; Gutiérrez-López M; Rubio-Garrido M; Fortuny C; Frick MA; Muñoz Medina L; Moreno S; Sanz J; Rojo P; Navarro ML; Holguín Á;
    Pediatr Infect Dis J; 2024 Jan; 43(1):40-48. PubMed ID: 37922511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
    Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
    PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.
    Avila-Rios S; Sued O; Rhee SY; Shafer RW; Reyes-Teran G; Ravasi G
    PLoS One; 2016; 11(6):e0158560. PubMed ID: 27355626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emergence of HIV-1 primary drug resistance genotypes among treatment-naïve men who have sex with men in high-prevalence areas in China.
    Yang J; Xing H; Niu J; Liao L; Ruan Y; He X; Feng Y; Li Z; Shao Y
    Arch Virol; 2013 Apr; 158(4):839-44. PubMed ID: 23224760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods.
    Hunt GM; Ledwaba J; Kalimashe M; Salimo A; Cibane S; Singh B; Puren A; Dean NE; Morris L; Jordan MR
    Antivir Ther; 2019; 24(3):203-210. PubMed ID: 30741163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
    Rhee SY; Clutter D; Fessel WJ; Klein D; Slome S; Pinsky BA; Marcus JL; Hurley L; Silverberg MJ; Kosakovsky Pond SL; Shafer RW
    Clin Infect Dis; 2019 Jan; 68(2):213-221. PubMed ID: 29846534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand.
    Sungkanuparph S; Pasomsub E; Chantratita W
    J Int Assoc Provid AIDS Care; 2014; 13(1):12-4. PubMed ID: 23708678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV pretreatment drug resistance trends in three geographic areas of Mexico.
    García-Morales C; Tapia-Trejo D; Quiroz-Morales VS; Navarro-Álvarez S; Barrera-Arellano CA; Casillas-Rodríguez J; Romero-Mora KA; Gómez-Palacio-Schjetnan M; Murakami-Ogasawara A; Ávila-Ríos S; Reyes-Terán G;
    J Antimicrob Chemother; 2017 Nov; 72(11):3149-3158. PubMed ID: 28961972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.
    Hassan AS; Mwaringa SM; Obonyo CA; Nabwera HM; Sanders EJ; Rinke de Wit TF; Cane PA; Berkley JA
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):129-35. PubMed ID: 22900472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil.
    Moura ME; Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):250-4. PubMed ID: 25411830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV drug resistance surveillance using pooled pyrosequencing.
    Ji H; Massé N; Tyler S; Liang B; Li Y; Merks H; Graham M; Sandstrom P; Brooks J
    PLoS One; 2010 Feb; 5(2):e9263. PubMed ID: 20174661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.
    Paraskevis D; Kostaki E; Magiorkinis G; Gargalianos P; Xylomenos G; Magiorkinis E; Lazanas M; Chini M; Nikolopoulos G; Skoutelis A; Papastamopoulos V; Antoniadou A; Papadopoulos A; Psichogiou M; Daikos GL; Oikonomopoulou M; Zavitsanou A; Chrysos G; Paparizos V; Kourkounti S; Sambatakou H; Sipsas NV; Lada M; Panagopoulos P; Maltezos E; Drimis S; Hatzakis A
    Infect Genet Evol; 2017 Oct; 54():183-191. PubMed ID: 28688977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.
    Yebra G; de Mulder M; Pérez-Elías MJ; Pérez-Molina JA; Galán JC; Llenas-García J; Moreno S; Holguín Á
    PLoS One; 2011; 6(10):e26757. PubMed ID: 22046345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.
    Arimide DA; Abebe A; Kebede Y; Adugna F; Tilahun T; Kassa D; Assefa Y; Balcha TT; Björkman P; Medstrand P
    PLoS One; 2018; 13(10):e0205446. PubMed ID: 30304061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
    Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006-17): impact on susceptibility to first-line strategies.
    Frange P; Avettand-Fenoel V; Veber F; Blanche S; Chaix ML
    J Antimicrob Chemother; 2018 Sep; 73(9):2475-2479. PubMed ID: 29846602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China.
    Zhao S; Feng Y; Hu J; Li Y; Zuo Z; Yan J; Zhang J; Cao P; Xu W; Li F; Li Y; Liao L; Ruan Y; Shao Y; Xing H
    Sci Rep; 2018 Aug; 8(1):12273. PubMed ID: 30115986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.
    Avila-Ríos S; García-Morales C; Tapia-Trejo D; Meza RI; Nuñez SM; Parham L; Flores NA; Valladares D; Pineda LM; Flores D; Motiño R; Umanzor V; Carbajal C; Murillo W; Lorenzana I; Palou EY; Reyes-Terán G
    PLoS One; 2015; 10(11):e0142604. PubMed ID: 26558396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.